Intra-Cellular Therapies Inc (NASDAQ:ITCI)

25.73
Delayed Data
As of Mar 03
 -0.20 / -0.77%
Today’s Change
12.67
Today|||52-Week Range
30.72
+45.78%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close25.93
Today’s open25.89
Day’s range25.39 - 26.24
Volume26,558
Average volume (3 months)51,763
Market cap$762.3M
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+4.29%
Earnings growth (this year)+39.10%
Earnings growth (next 5 years)--
Revenue growth (last year)-12.22%
P/E ratioNM
Price/Sales126.13
Price/Book18.17

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...0.000.00%
OMEDOncoMed Pharmaceutic...+1.35+5.49%
PRTAProthena Corporation...-0.84-3.17%
FOLDAmicus Therapeutics ...+0.03+0.36%
Data as of 4:00pm ET, 03/03/2015

Financials

Next reporting dateMarch 24, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$2.7M
Annual profit (last year)-$26.9M
Net profit margin-981.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
Chief Financial Officer, Secretary &
VP
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account